Crystalline forms of an antiviral benzimidazole compound
US9163052B2 · kind B2 · utility
0Cited by
16References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 2011 |
| Grant date | Oct 20, 2015 |
| Priority date | — |
| Expiry date | Jan 25, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to crystalline forms of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole, pharmaceutical compositions comprising the same, processes for preparing the same, and their use in medical therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.